First Patient Enrolled In Global Phase III Study Of Bevacizumab And Trastuzumab In Early Breast Cancer
A new international study for women with HER2-positive breast cancer is open for enrollment.
More: continued here
A new international study for women with HER2-positive breast cancer is open for enrollment.
More: continued here
|